Ledger.Open graph →
SEC Form D · filed February 19, 2016

Aralez Pharmaceuticals Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Vancouver, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Andrew I. Koven · Vancouver, British Columbia, CanadaExecAdrian Adams · Vancouver, British Columbia, CanadaExec · DirectorNeal F. Fowler · Vancouver, British Columbia, CanadaDirectorF. Martin B. Thrasher · Vancouver, British Columbia, CanadaDirectorEric L. Trachtenberg · MONTREAL, Quebec, CanadaExecScott J. Charles · Vancouver, British Columbia, CanadaExecKenneth B. Lee Jr · Vancouver, British Columbia, CanadaDirectorArthur S. Kirsch · Vancouver, British Columbia, CanadaDirectorMark A. Glickman · Vancouver, British Columbia, CanadaExecJason M. Aryeh · Vancouver, British Columbia, CanadaDirectorRob F. Harris · Vancouver, British Columbia, CanadaDirectorJames P. Tursi, M.D · Vancouver, British Columbia, CanadaExecSeth A. Rudnick, M.D · Westport, CTDirectorJennifer L. Armstrong · Vancouver, British Columbia, CanadaExecAndrew I. Koven · Vancouver, British Columbia, CanadaExecEric L. Trachtenberg · Vancouver, British Columbia, CanadaExecScott J. Charles · Vancouver, British Columbia, CanadaExecKenneth B. Lee Jr · Vancouver, British Columbia, CanadaDirectorArthur S. Kirsch · Vancouver, British Columbia, CanadaDirectorAdrian Adams · Vancouver, British Columbia, CanadaExec · DirectorMark A. Glickman · Vancouver, British Columbia, CanadaExecJason M. Aryeh · Vancouver, British Columbia, CanadaDirectorNeal F. Fowler · Vancouver, British Columbia, CanadaDirectorRob F. Harris · Vancouver, British Columbia, CanadaDirectorJames P. Tursi, M.D · Vancouver, British Columbia, CanadaExecSeth A. Rudnick, M.D · Vancouver, British Columbia, CanadaDirectorJennifer L. Armstrong · Vancouver, British Columbia, CanadaExecF. Martin B. Thrasher · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗